Venkat Bhat - Publications

Affiliations: 
Interventional Psychiatry Program St. Michael's Hospital, University of Toronto 

40 high-probability publications. We are testing a new system for linking publications to authors. You can help! If you notice any inaccuracies, please sign in and mark papers as correct or incorrect matches. If you identify any major omissions or other inaccuracies in the publication list, please let us know.

Year Citation  Score
2024 Palmisano A, Pandit S, Smeralda CL, Demchenko I, Rossi S, Battelli L, Rivolta D, Bhat V, Santarnecchi E. The Pathophysiological Underpinnings of Gamma-Band Alterations in Psychiatric Disorders. Life (Basel, Switzerland). 14. PMID 38792599 DOI: 10.3390/life14050578  0.732
2024 Meshkat S, Tassone VK, Pang H, Wu M, Jung H, Lou W, Bhat V. Adults with depressive symptoms have lower odds of dietary supplement use. Plos One. 19: e0302637. PMID 38718014 DOI: 10.1371/journal.pone.0302637  0.319
2024 Lam RW, Kennedy SH, Adams C, Bahji A, Beaulieu S, Bhat V, Blier P, Blumberger DM, Brietzke E, Chakrabarty T, Do A, Frey BN, Giacobbe P, Gratzer D, Grigoriadis S, et al. Canadian Network for Mood and Anxiety Treatments (CANMAT) 2023 Update on Clinical Guidelines for Management of Major Depressive Disorder in Adults: Réseau canadien pour les traitements de l'humeur et de l'anxiété (CANMAT) 2023 : Mise à jour des lignes directrices cliniques pour la prise en charge du trouble dépressif majeur chez les adultes. Canadian Journal of Psychiatry. Revue Canadienne De Psychiatrie. 7067437241245384. PMID 38711351 DOI: 10.1177/07067437241245384  0.527
2024 Demchenko I, Swiderski A, Liu H, Jung H, Lou W, Bhat V. Botulinum Toxin Injections for Psychiatric Disorders: A Systematic Review of the Clinical Trial Landscape. Toxins. 16. PMID 38668616 DOI: 10.3390/toxins16040191  0.74
2024 Tassone VK, Gholamali Nezhad F, Demchenko I, Rueda A, Bhat V. Amygdala biomarkers of treatment response in major depressive disorder: An fMRI systematic review of SSRI antidepressants. Psychiatry Research. Neuroimaging. 338: 111777. PMID 38183847 DOI: 10.1016/j.pscychresns.2023.111777  0.743
2023 Islam F, Magarbeh L, Elsheikh SSM, Kloiber S, Espinola CW, Bhat V, Frey BN, Milev R, Soares CN, Parikh SV, Placenza F, Hassel S, Taylor VH, Leri F, Blier P, et al. Influence of , , and Gene Variants and Serum Levels of Escitalopram and Aripiprazole on Treatment-Emergent Sexual Dysfunction: A Canadian Biomarker Integration Network in Depression 1 (CAN-BIND 1) Study. Canadian Journal of Psychiatry. Revue Canadienne De Psychiatrie. 7067437231203433. PMID 37796764 DOI: 10.1177/07067437231203433  0.503
2023 Demchenko I, Desai N, Iwasa SN, Gholamali Nezhad F, Zariffa J, Kennedy SH, Rule NO, Cohn JF, Popovic MR, Mulsant BH, Bhat V. Manipulating facial musculature with functional electrical stimulation as an intervention for major depressive disorder: a focused search of literature for a proposal. Journal of Neuroengineering and Rehabilitation. 20: 64. PMID 37193985 DOI: 10.1186/s12984-023-01187-8  0.76
2023 Demchenko I, Tassone VK, Dunnett S, Balachandar A, Li S, Anderson M, Daskalakis ZJ, Foley K, Karkouti K, Kennedy SH, Ladha KS, Robertson J, Vaisman A, Koczerginski D, Parikh SV, ... ... Bhat V, et al. Impact of COVID-19 on electroconvulsive therapy practice across Canadian provinces during the first wave of the pandemic. Bmc Psychiatry. 23: 327. PMID 37165333 DOI: 10.1186/s12888-023-04832-7  0.707
2023 Dama M, Wu M, Tassone VK, Demchenko I, Frey BN, Milev RV, Ravindran AV, Parikh SV, Rotzinger S, Lou W, Lam RW, Kennedy SH, Bhat V. The course of insomnia symptoms during the acute treatment of major depressive disorder: A CAN-BIND-1 report. Psychiatry Research. 325: 115222. PMID 37163883 DOI: 10.1016/j.psychres.2023.115222  0.738
2023 Sussman D, Tassone VK, Gholamali Nezhad F, Wu M, Adamsahib F, Mattina GF, Pazmino-Canizares J, Demchenko I, Jung H, Lou W, Ladha KS, Bhat V. Local Injection for Treating Mood Disorders (LIFT-MOOD): A Pilot Feasibility RCT of Stellate Ganglion Block for Treatment-Resistant Depression. Chronic Stress (Thousand Oaks, Calif.). 7: 24705470231160315. PMID 36895443 DOI: 10.1177/24705470231160315  0.761
2022 Balachandran A, Tassone VK, Adamsahib F, Di Passa AM, Kuburi S, Demchenko I, Ladha KS, Bhat V. Efficacy of ketamine for comorbid depression and acute or chronic pain: A systematic review. Frontiers in Pain Research (Lausanne, Switzerland). 3: 1022767. PMID 36353699 DOI: 10.3389/fpain.2022.1022767  0.727
2022 Tassone VK, Demchenko I, Salvo J, Mahmood R, Di Passa AM, Kuburi S, Rueda A, Bhat V. Contrasting the amygdala activity and functional connectivity profile between antidepressant-free participants with major depressive disorder and healthy controls: A systematic review of comparative fMRI studies. Psychiatry Research. Neuroimaging. 325: 111517. PMID 35944425 DOI: 10.1016/j.pscychresns.2022.111517  0.734
2022 Kuburi S, Di Passa AM, Tassone VK, Mahmood R, Lalovic A, Ladha KS, Dunlop K, Rizvi S, Demchenko I, Bhat V. Neuroimaging Correlates of Treatment Response with Psychedelics in Major Depressive Disorder: A Systematic Review. Chronic Stress (Thousand Oaks, Calif.). 6: 24705470221115342. PMID 35936944 DOI: 10.1177/24705470221115342  0.753
2022 Lucia M, Romanella SM, Di Lorenzo G, Demchenko I, Bhat V, Rossi S, Santarnecchi E. Neural Correlates of N-back Task Performance and Proposal for Corresponding Neuromodulation Targets in Psychiatric and Neurodevelopmental Disorders. Psychiatry and Clinical Neurosciences. PMID 35773784 DOI: 10.1111/pcn.13442  0.712
2022 Drozdz SJ, Goel A, McGarr MW, Katz J, Ritvo P, Mattina GF, Bhat V, Diep C, Ladha KS. Ketamine Assisted Psychotherapy: A Systematic Narrative Review of the Literature. Journal of Pain Research. 15: 1691-1706. PMID 35734507 DOI: 10.2147/JPR.S360733  0.345
2022 Demchenko I, Tassone VK, Kennedy SH, Dunlop K, Bhat V. Intrinsic Connectivity Networks of Glutamate-Mediated Antidepressant Response: A Neuroimaging Review. Frontiers in Psychiatry. 13: 864902. PMID 35722550 DOI: 10.3389/fpsyt.2022.864902  0.742
2022 Espinola CW, Khoo Y, Parmar R, Demchenko I, Frey BN, Milev RV, Ravindran AV, Parikh SV, Ho K, Rotzinger S, Lou W, Lam RW, Kennedy SH, Bhat V. Males and females differ in reported sexual functioning with escitalopram treatment for major depressive disorder: A CAN-BIND-1 study report. Journal of Psychopharmacology (Oxford, England). 2698811221095832. PMID 35546043 DOI: 10.1177/02698811221095832  0.761
2022 Diep C, Rosenek N, Khoo Y, Gandhi W, van Reekum CM, Ravindran AV, Ladha KS, Frey BN, Milev RV, Rotzinger S, Lam RW, Kennedy SH, Lou W, Salomons T, Bhat V. Pain severity and pain interference during major depressive episodes treated with escitalopram and aripiprazole adjunctive therapy: a CAN-BIND-1 report. Psychiatry Research. 312: 114557. PMID 35461118 DOI: 10.1016/j.psychres.2022.114557  0.466
2022 Liu H, Kerzner J, Demchenko I, Wijeysundera DN, Kennedy SH, Ladha KS, Bhat V. Nitrous Oxide for the Treatment of Psychiatric Disorders: A Systematic Review of the Clinical Trial Landscape. Acta Psychiatrica Scandinavica. PMID 35353901 DOI: 10.1111/acps.13432  0.729
2022 Espinola CW, Khoo Y, Parmar R, Demchenko I, Frey BN, Milev RV, Ravindran AV, Parikh SV, Ho K, Rotzinger S, Lou W, Lam RW, Kennedy SH, Bhat V. Pretreatment anxious depression as a predictor of side effect frequency and severity in escitalopram and aripiprazole adjunctive therapy. Brain and Behavior. e2555. PMID 35333448 DOI: 10.1002/brb3.2555  0.764
2022 Elias GJB, Germann J, Loh A, Boutet A, Pancholi A, Beyn ME, Bhat V, Woodside DB, Giacobbe P, Kennedy SH, Lozano AM. Habenular Involvement in Response to Subcallosal Cingulate Deep Brain Stimulation for Depression. Frontiers in Psychiatry. 13: 810777. PMID 35185654 DOI: 10.3389/fpsyt.2022.810777  0.541
2022 Anteraper SA, Guell X, Lee YJ, Raya J, Demchenko I, Churchill NW, Frey BN, Hassel S, Lam RW, MacQueen GM, Milev R, Schweizer TA, Strother SC, Whitfield-Gabrieli S, Kennedy SH, ... Bhat V, et al. Cerebello-cerebral Functional Connectivity Networks in Major Depressive Disorder: a CAN-BIND-1 Study Report. Cerebellum (London, England). PMID 35023065 DOI: 10.1007/s12311-021-01353-5  0.754
2022 Ceniti AK, Abdelmoemin WR, Ho K, Kang Y, Placenza F, Laframboise R, Bhat V, Foster JA, Frey BN, Lam RW, Milev R, Rotzinger S, Soares CN, Uher R, Kennedy SH. "One Degree of Separation": A Mixed-Methods Evaluation of Canadian Mental Health Care User and Provider Experiences With Remote Care During COVID-19. Canadian Journal of Psychiatry. Revue Canadienne De Psychiatrie. 7067437211070656. PMID 34986035 DOI: 10.1177/07067437211070656  0.314
2022 Vaccarino SR, Adamsahib F, Milev RV, Parikh SV, Lam RW, Blier P, Kennedy SH, Ladha KS, Bhat V. The Effects of Ketamine on Cognition in Unipolar and Bipolar Depression: A Systematic Review. The Journal of Clinical Psychiatry. 83. PMID 34985832 DOI: 10.4088/JCP.21r13870  0.586
2021 Khoo Y, Demchenko I, Frey BN, Milev RV, Ravindran AV, Parikh SV, Ho K, Rotzinger S, Lou W, Lam RW, Kennedy SH, Bhat V. Baseline Anxiety, and Early Anxiety/Depression Improvement in Anxious Depression Predicts Treatment Outcomes with Escitalopram: A CAN-BIND-1 Study Report. Journal of Affective Disorders. PMID 34921820 DOI: 10.1016/j.jad.2021.12.027  0.766
2021 Elias GJB, Germann J, Boutet A, Loh A, Li B, Pancholi A, Beyn ME, Naheed A, Bennett N, Pinto J, Bhat V, Giacobbe P, Woodside DB, Kennedy SH, Lozano AM. 3 T MRI of rapid brain activity changes driven by subcallosal cingulate deep brain stimulation. Brain : a Journal of Neurology. PMID 34919630 DOI: 10.1093/brain/awab447  0.429
2021 Kerzner J, Liu H, Demchenko I, Sussman D, Wijeysundera DN, Kennedy SH, Ladha KS, Bhat V. Stellate Ganglion Block for Psychiatric Disorders: A Systematic Review of the Clinical Research Landscape. Chronic Stress (Thousand Oaks, Calif.). 5: 24705470211055176. PMID 34901677 DOI: 10.1177/24705470211055176  0.762
2021 Rnic K, Jung YE, Torres I, Chakrabarty T, LeMoult J, Vaccarino AL, Morton E, Bhat V, Giacobbe P, McInerney S, Frey BN, Milev RV, Müller D, Ravindran AV, Rotzinger S, et al. Association between discrepancy in objective and subjective cognitive abilities and treatment response in patients with major depressive disorder: A CAN-BIND-1 study report. Journal of Affective Disorders. 295: 1095-1101. PMID 34706420 DOI: 10.1016/j.jad.2021.09.002  0.491
2021 Demchenko I, Blumberger DM, Flint AJ, Anderson M, Daskalakis ZJ, Foley K, Karkouti K, Kennedy SH, Ladha KS, Robertson J, Vaisman A, Koczerginski D, Parikh SV, Bhat V. Electroconvulsive Therapy in Canada During the First Wave of COVID-19: Results of the "What Happened" National Survey. The Journal of Ect. PMID 34519681 DOI: 10.1097/YCT.0000000000000801  0.683
2021 Elias GJB, Boutet A, Parmar R, Wong EHY, Germann J, Loh A, Paff M, Pancholi A, Gwun D, Kin CTCB, Gouveia FV, Harmsen IE, Beyn ME, Santarnecchi E, Fasano A, ... ... Bhat V, et al. Neuromodulatory treatments for psychiatric disease: A comprehensive survey of the clinical trial landscape. Brain Stimulation. PMID 34461326 DOI: 10.1016/j.brs.2021.08.021  0.46
2021 Elias GJB, Germann J, Boutet A, Pancholi A, Beyn ME, Bhatia K, Neudorfer C, Loh A, Rizvi SJ, Bhat V, Giacobbe P, Woodside DB, Kennedy SH, Lozano AM. Structuro-functional surrogates of response to subcallosal cingulate deep brain stimulation for depression. Brain : a Journal of Neurology. PMID 34324658 DOI: 10.1093/brain/awab284  0.466
2021 Morton E, Bhat V, Giacobbe P, Lou W, Michalak EE, McInerney S, Chakrabarty T, Frey BN, Milev RV, Müller DJ, Parikh SV, Rotzinger S, Kennedy SH, Lam RW. Predictors of Quality of Life Improvement with Escitalopram and Adjunctive Aripiprazole in Patients with Major Depressive Disorder: A CAN-BIND Study Report. Cns Drugs. 35: 439-450. PMID 33860922 DOI: 10.1007/s40263-021-00803-2  0.57
2021 Morton E, Bhat V, Giacobbe P, Lou W, Michalak EE, Chakrabarty T, Frey BN, Milev RV, Müller DJ, Parikh SV, Rotzinger S, Kennedy SH, Lam RW. Impacts on Quality of Life with Escitalopram Monotherapy and Aripiprazole Augmentation in Patients with Major Depressive Disorder: A CAN-BIND Report. Pharmacopsychiatry. PMID 33652477 DOI: 10.1055/a-1385-0263  0.562
2020 Phillips JL, Jaworska N, Kamler E, Bhat V, Blier J, Foster JA, Hassel S, Ho K, McMurray L, Milev R, Moazamigoudarzi Z, Placenza FM, Richard-Devantoy S, Rotzinger S, Turecki G, et al. A randomized, crossover comparison of ketamine and electroconvulsive therapy for treatment of major depressive episodes: a Canadian biomarker integration network in depression (CAN-BIND) study protocol. Bmc Psychiatry. 20: 268. PMID 32487236 DOI: 10.1186/S12888-020-02672-3  0.577
2019 Vaccarino SR, McInerney SJ, Kennedy SH, Bhat V. The Potential Procognitive Effects of Modafinil in Major Depressive Disorder: A Systematic Review. The Journal of Clinical Psychiatry. 80. PMID 31599501 DOI: 10.4088/Jcp.19R12767  0.604
2019 Fonseka TM, Bhat V, Kennedy SH. The utility of artificial intelligence in suicide risk prediction and the management of suicidal behaviors. The Australian and New Zealand Journal of Psychiatry. 4867419864428. PMID 31347389 DOI: 10.1177/0004867419864428  0.347
2019 Dhanju S, Kennedy SH, Abbey S, Katz J, Weinrib A, Clarke H, Bhat V, Ladha K. The impact of comorbid pain and depression in the United States: results from a nationally representative survey. Scandinavian Journal of Pain. PMID 30759071 DOI: 10.1515/Sjpain-2018-0323  0.487
2018 Bhat V, Kennedy SH. Vagus Nerve Stimulation: A Treatment in Evolution. Cognitive and Behavioral Neurology : Official Journal of the Society For Behavioral and Cognitive Neurology. 31: 99-100. PMID 29927801 DOI: 10.1097/Wnn.0000000000000155  0.341
2017 Bhat V, Kennedy SH. Recognition and management of antidepressant discontinuation syndrome. Journal of Psychiatry & Neuroscience : Jpn. 42: E7-E8. PMID 28639936 DOI: 10.1503/Jpn.170022  0.34
2016 Kennedy SH, Lam RW, McIntyre RS, Tourjman SV, Bhat V, Blier P, Hasnain M, Jollant F, Levitt AJ, MacQueen GM, McInerney SJ, McIntosh D, Milev RV, Müller DJ, Parikh SV, et al. Canadian Network for Mood and Anxiety Treatments (CANMAT) 2016 Clinical Guidelines for the Management of Adults with Major Depressive Disorder: Section 3. Pharmacological Treatments. Canadian Journal of Psychiatry. Revue Canadienne De Psychiatrie. PMID 27486148 DOI: 10.1177/0706743716659417  0.58
Show low-probability matches.